Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Glioblastoma 7Urinary Bladder Neoplasms 5Lung Neoplasms 5Glioma 5Breast Neoplasms 5Esophageal Neoplasms 4Burkitt Lymphoma 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 3Carcinoma 3Sarcoma, Ewing 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Mouth Neoplasms 2Mesothelioma, Malignant 2Medulloblastoma 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Gliosarcoma 2Ganglioneuroblastoma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Astrocytoma 2Adenocarcinoma of Lung 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1

Interventions

Rituximab 11Cyclophosphamide 8ibrutinib 6acalabrutinib 6venetoclax 5fludarabine 4Whole-Body Irradiation 4zanubrutinib 3fludarabine phosphate 3Vincristine 3Peripheral Blood Stem Cell Transplantation 3Methotrexate 3Magnetic Resonance Spectroscopy 3Doxorubicin 3Cytarabine 3Cyclosporine 3CT-P10 3Bendamustine Hydrochloride 3merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Mycophenolic Acid 2Melphalan 2Etoposide 2Dexamethasone 2Calcium Dobesilate 2treosulfan 1palbociclib 1obinutuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Mantle-Cell × Radiation × 30 days × Clear all
NCT04054167 2026-06-03

Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
51 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡